Company records / glycomine.com

Glycomine

Glycomine (glycomine.com): 5 changes recorded in its website history since October 2015. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

HeadlineBetween 14 August 2020 and 24 January 2022
BeforeDeveloping therapies for critical unmet orphan diseases of glycosylation
AfterThe Missing Piece For Rare Genetic Diseases
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
HiringBetween 7 January 2019 and 14 August 2020
Added a careers page.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
HeadlineBetween 19 January 2018 and 7 January 2019
BeforeDeveloping replacement therapies for rare genetic disorders
AfterDeveloping therapies for critical unmet orphan diseases of glycosylation
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
FundingBetween 29 November 2016 and 19 January 2018
Announced on its homepage: “Announces $12 Million Series A Financing to Advance a New Generation of Replacement Therapies for Rare Diseases Read the press release Re…”.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation
FundingBetween 12 October 2015 and 29 November 2016
Announced on its homepage: “company’s fundraising efforts for Seed and Series A raising nearly $13M to-date.”.
Observed on the company’s website; business claims are not independently verified.
earlier archived page later archived page Link to observation

First recorded website

Observed 12 October 2015

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

Developing nanomedicines for rare genetic disorders

Homepage

Compliance claims on the website: FDA APPROVED

archived page Link to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

January 2022 – November 2026 · 6 captures · latest observed messagingThe Missing Piece For Rare Genetic Diseases
We are developing a PMM2-CDG substrate replacement therapy. GLM101 is a mannose-1 phosphate treatment.
This wording observed 6 November 2026.
current websiteHistorical capture not publicly available
Inspect 6 captures in this group
- 24 January 2022 · The Missing Piece For Rare Genetic Diseases archived page
- 9 January 2023 · The Missing Piece For Rare Genetic Diseases archived page
- 4 January 2024 · The Missing Piece For Rare Genetic Diseases archived page
- 19 July 2025 · The Missing Piece For Rare Genetic Diseases archived page
- 9 July 2026 · The Missing Piece For Rare Genetic Diseases archived page
- 6 November 2026 · The Missing Piece For Rare Genetic Diseases current websiteHistorical capture not publicly available
January 2019 – August 2020 · 2 capturesDeveloping therapies for critical unmet orphan diseases of glycosylation
This wording observed 14 August 2020.
archived page
Inspect 2 captures in this group
- 7 January 2019 · Developing therapies for critical unmet orphan diseases of glycosylation archived page
- 14 August 2020 · Developing therapies for critical unmet orphan diseases of glycosylation archived page
October 2015 – January 2018 · 3 capturesDeveloping replacement therapies for rare genetic disorders
This wording observed 19 January 2018.
archived page
Inspect 3 captures in this group
- 12 October 2015 · Developing nanomedicines for rare genetic disorders archived page
- 29 November 2016 · Developing replacement therapies for rare genetic disorders archived page
- 19 January 2018 · Developing replacement therapies for rare genetic disorders archived page

Cite this record

StartupHistory, “Glycomine” company record, https://startuphistory.org/c/glycomine.com

Machine-readable: /c/glycomine.com.json. How changes are found: method.